Journal of cancer and Therapeutics Journal of cancer and Therapeutics Journal of cancer and Therapeutics


Author Instruction


Journal of Cancer Research and Therapeutics(JCRT) accepts articles of all areas related to Cancer and therapeutics on monthly basis. JCRT welcomes the submission of manuscripts from authors that meet the specific criteria of significance and scientific excellence. All the Accepted Papers will be published approximately within 10 days after acceptance from the editorial board. The Journal of Cancer Research and Therapeutics has received a major response from research and review articles in the recent volumes and issue releases.
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Journal of Cancer Research and Therapeutics alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the Journal of Cancer Research and Therapeutics readers are also liable to be rejected at this stage itself.
Authors are requested to submit their manuscript at www.jcrt.org/submitmenuscript or send as an e-mail attachment to the Editorial Office at editor@jcrt.com
The Authors will received the confirmation mail/Menuscript number within 72 hours from the submission, Alternatively you can contact the Editorial Board through the contact form provided in the webisite after 72 hours of submission.


Article Processing Charges
Arjyopa or Journal on Cancer Research and Therapeutics is a self-financed and we does not receive any funding from any institution/government. Hence, the Journal operates solely through processing charges we receive from the authors and some academic/corporate sponsors. The handling fee is required to meet its maintenance. Being an Open Access Journal, JCRT does not collect subscription charges from readers that enjoy free online access to the articles. Authors are hence required to pay a fair handling fee for processing their articles. However, there are no submission charges. Authors are required to make payment only after their manuscript has been accepted for publication.


Journal Name Publication Fees(National) Publication Fees(Internationl)
Journal of Cancer Research and Therapeutics INR 10000 USD 500


Submission of an Article


Title Page/First Page File/covering letter
This file should provide
  • The type of manuscript (original article, case report, review article, Letter to editor, Images, etc.) title of the manuscript, running title, names of all authors/ contributors (with their highest academic degrees, designation and affiliations) and name(s) of department(s) and/ or institution(s) to which the work should be credited, . All information which can reveal your identity should be here. Use text/rtf/doc files. Do not zip the files.
  • The total number of pages, total number of photographs and word counts separately for abstract and for the text (excluding the references, tables and abstract), word counts for introduction + discussion in case of an original article;
  • Source(s) of support in the form of grants, equipment, drugs, or all of these;
  • Acknowledgement, if any. One or more statements should specify 1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; 2) acknowledgments of technical help; and 3) acknowledgments of financial and material support, which should specify the nature of the support. This should be included in the title page of the manuscript and not in the main article file.
  • If the manuscript was presented as part at a meeting, the organization, place, and exact date on which it was read. A full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or very similar work. Any such work should be referred to specifically, and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to handle the matter.
  • Registration number in case of a clinical trial and where it is registered (name of the registry and its URL)
  • Conflicts of Interest of each author/ contributor. A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an authors' form
  • Criteria for inclusion in the authors’/ contributors’ list
  • A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work, if that information is not provided in another form (see below); and
  • The name, address, e-mail, and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs, if that information is not included on the manuscript itself.


Blinded Article file:
The main text of the article, beginning from Abstract till References (including tables) should be in this file. The file must not contain any mention of the authors' names or initials or the institution at which the study was done or acknowledgements. Page headers/running title can include the title but not the authors' names. Manuscripts not in compliance with the Journal's blinding policy will be returned to the corresponding author. Use rtf/doc files. Do not zip the files. Limit the file size to 1 MB. Do not incorporate images in the file. If file size is large, graphs can be submitted as images separately without incorporating them in the article file to reduce the size of the file. The pages should be numbered consecutively, beginning with the first page of the blinded article file.


Images:
Submit good quality color images. Each image should be less than 2 MB in size. Size of the image can be reduced by decreasing the actual height and width of the images (keep up to 1600 x 1200 pixels or 5-6 inches). Images can be submitted as jpeg files. Do not zip the files. Legends for the figures/images should be included at the end of the article file.


The contributors' / copyright transfer form:
The templates has to be submitted in original with the signatures of all the contributors within 3 days of submission via courier or email as a scanned image. Print ready hard copies of the images (one set) or digital images should be sent to the journal office at the time of submitting revised manuscript. High resolution images (up to 5 MB each) can be sent by email.


Guidelines for Research Articles
  • Research articles are articles written based on the empirical/secondary data collected using a clearly defined research methodology, where conclusion/s is drawn from the analysis of the data collected.
  • The information must be based on original research that adds to the body of knowledge in Cancer Science & Therapy.
  • Article/s should provide a critical description or analysis of the data presented while adding new and rapidly evolving areas in the field.
  • Include an abstract of at least 300 words with 7 to 10 important keywords.
  • The abstract should be divided into Objective, Methods, Results, and Conclusion.
  • Research articles must adhere to a format constituting the introduction followed by a brief review of relevant literature, methodology applied (to collect the data), discussion and References, Tables, and Figure Legends.


Review Articles
  • Review articles are written based mostly on secondary data that is falling in line with the theme of the journal. They are brief, yet critical discussions on a specific aspect of the subject concerned. Reviews generally start with the statement of the problem with a brief abstract of 300 words and few key words. Introduction generally brings the issue forward to the readers followed by analytical discussion with the help of necessary tables, graphs, pictures and illustrations wherever necessary. It summarizes the topic with a conclusion. All the statements or observations in the review articles must be based on necessary citations, providing complete reference at the end of the article.


Commentaries
  • Commentaries are opinion articles written mostly by the veteran and experienced writers on a specific development, recent innovation or research findings that fall in line with the theme of the journal. They are very brief articles with the title and abstract that provides the gist of the topic to be discussed, with few key words. It straight away states the problems and provides a thorough analysis with the help of the illustrations, graphs and tables if necessary. It summarizes the topic with a brief conclusion, citing the references at the end.


Case Study
  • Case studies are accepted with a view to add additional information related to the investigative research that advances in the field of Cancer Science & Therapy
  • It should add value to the main content/article submitted, by providing key insights about the core area. Cases reports must be brief and follow a clear format such as Cases and Methods Section (That describe the nature of the clinical issue and the methodology adopt to address it), discussion section that analyzes the case and a Conclusion section that sums up the entire case


Editorials
  • Editorials are concise commentaries on a currently published article/issue on Cancer Science & Therapy. Editorial office may approach for any such works and authors must submit it within three weeks from the date of receiving invitation.


Clinical Images
  • Clinical Images are nothing but photographic depictions of Cancer Science & Therapy and it should not exceed more than 5 figures with a description, not exceeding 300 words. Generally no references and citations are required here. If necessary, only three references can be allowed.
  • Do not add separate figure legends to clinical images; the entire clinical image text is the figure legend. Images should be submitted with the manuscript in one of the following formats: .tiff (preferred) or .eps.


Tables
  • Tables should be self-explanatory and should not duplicate textual material.
  • Tables with more than 10 columns and 25 rows are not acceptable.
  • Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each.
  • Place explanatory matter in footnotes, not in the heading.
  • Explain in footnotes all non-standard abbreviations that are used in each table.
  • Obtain permission for all fully borrowed, adapted, and modified tables and provide a credit line in the footnote.
  • For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||,¶ , **, ††, ‡‡
  • Tables with their legends should be provided at the end of the text after the references. The tables along with their number should be cited at the relevant place in the text


Illustrations (Figures)
  • Upload the images in JPEG format. The file size should be within 1024 kb in size while uploading.
  • Figures should be numbered consecutively according to the order in which they have been first cited in the text.
  • Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column.
  • Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen.
  • Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.
  • When graphs, scatter-grams or histograms are submitted the numerical data on which they are based should also be supplied.
  • The photographs and figures should be trimmed to remove all the unwanted areas.
  • If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.
  • If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for such figures.
  • Legends for illustrations: Type or print out legends (maximum 40 words, excluding the credit line) for illustrations using double spacing, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one in the legend. Explain the internal scale (magnification) and identify the method of staining in photomicrographs.
  • Final figures for print production: Send sharp, glossy, un-mounted, color photographic prints, with height of 4 inches and width of 6 inches at the time of submitting the revised manuscript. Print outs of digital photographs are not acceptable. If digital images are the only source of images, ensure that the image has minimum resolution of 300 dpi or 1800 x 1600 pixels in TIFF format. Send the images on a CD. Each figure should have a label pasted (avoid use of liquid gum for pasting) on its back indicating the number of the figure, the running title, top of the figure and the legends of the figure. Do not write the contributor/s' name/s. Do not write on the back of figures, scratch, or mark them by using paper clips.
  • The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.


Language and Grammar
  • Uniformly American English
  • Write the full term for each abbreviation at its first use in the title, abstract, keywords and text separately unless it is a standard unit of measure. Numerals from 1 to 10 spelt out
  • Numerals at the beginning of the sentence spelt out
  • Check the manuscript for spelling, grammar and punctuation errors
  • If a brand name is cited, supply the manufacturer's name and address (city and state/country).
  • Species names should be in italics


Authors
  • Last name and given name provided along with Middle name initials (where applicable)
  • Author for correspondence, with e-mail address provided
  • Number of contributors restricted as per the instructions
  • Identity not revealed in paper except title page (e.g. name of the institute in Methods, citing previous study as 'our study', names on figure labels, name of institute in photographs, etc.)


Presentation and format
  • Double spacing
  • Margins 2.5 cm from all four sides
  • Page numbers included at bottom
  • Title page contains all the desired information
  • Running title provided (not more than 50 characters)
  • Abstract page contains the full title of the manuscript
  • Abstract provided (structured abstract of 250 words for original articles, unstructured abstracts of about 150 words for all other manuscripts excluding letters to the Editor)
  • Key words provided (three or more)
  • Introduction of 75-100 words
  • Headings in title case (not ALL CAPITALS)
  • The references cited in the text should be after punctuation marks, in superscript with square bracket.
  • References according to the journal's instructions, punctuation marks checked
  • Send the article file without ‘Track Changes’


Letters to the Editor/Concise Communications
  • Letters to the editor should be limited to commentaries on previous articles published with specific reference to issues and causes related to it. It should be concise, comprehensive and brief reports of cases or research findings. It does not follow a format such as abstract, subheads, or acknowledgments. It is more a response or the opinion of the reader on a particular article published and should reach the editor within 6 months of article publication.


Acknowledgement
  • This section includes acknowledgment of people, grant details, funds, etc.
  • Note: If an author fails to submit his/her work as per the above instructions, they are requested to maintain clear titles namely headings, subheading


References:
  • Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. All personal communications should be supported by a letter from the relevant authors.
  • Arjyopa uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Multiple citations within a single set of brackets should be separated by commas. When there are three or more sequential citations, they should be given as a range. Example: "... now enable biologists to simultaneously monitor the expression of thousands of genes in a single experiment [1,5-7,28]". Make sure the parts of the manuscript are in the correct order for the relevant journal before ordering the citations. Figure captions and tables should be at the end of the manuscript.
  • Authors are requested to provide at least one online link for each reference as following (preferably PubMed). Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial. Please use the following style for the reference list:


Copyright
  • All works published by Arjyopa are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.




Journal of cancer and Therapeutics
Journal of cancer and Therapeutics








CONTACT US


ARJYOPA
#2, RBC Road, Dum Dum, Gora Bazar
Kolkata - 700028, WestBengal, India
Ph: +91 9903058585 / +91 9706182257
E: enquiry@cancerjournal.org / contact@cancerjournal.info


WRITE TO US
Journal of cancer and Therapeutics
© 2017- 2019 Arjyopa - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version